{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T18:07:18Z","timestamp":1776535638139,"version":"3.51.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,29]]},"DOI":"10.7759\/cureus.83195","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T17:37:04Z","timestamp":1745948224000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Daptomycin-Induced Eosinophilic Pneumonia and Its Management Insights"],"prefix":"10.7759","author":[{"given":"Diaz Saez","family":"Yordanka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant","family":"Allena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetha","family":"Doddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelanjana","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trupti","family":"Vakde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2165\/00151829-200605010-00002","article-title":"Nosocomial pneumonia: rationalizing the approach to empirical therapy","volume":"5","author":"Andriesse GI","year":"2006","unstructured":"Andriesse GI, Verhoef J. Nosocomial pneumonia: rationalizing the approach to empirical therapy. Treat Respir Med. 2006, 5:11-30. 10.2165\/00151829-200605010-00002","journal-title":"Treat Respir Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/1874306401206010063","article-title":"Drug induced interstitial lung disease","volume":"6","author":"Schwaiblmair M","year":"2012","unstructured":"Schwaiblmair M, Behr W, Haeckel T, M\u00e4rkl B, Foerg W, Berghaus T. Drug induced interstitial lung disease. Open Respir Med J. 2012, 6:63-74. 10.2174\/1874306401206010063","journal-title":"Open Respir Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2020.12.005","article-title":"Projected economic burden of periprosthetic joint infection of the hip and knee in the United States","volume":"36","author":"Premkumar A","year":"2021","unstructured":"Premkumar A, Kolin DA, Farley KX, Wilson JM, McLawhorn AS, Cross MB, Sculco PK. Projected economic burden of periprosthetic joint infection of the hip and knee in the United States. J Arthroplasty. 2021, 36:1484-1489.e3. 10.1016\/j.arth.2020.12.005","journal-title":"J Arthroplasty"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt512","article-title":"Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study","volume":"69","author":"Shrestha NK","year":"2014","unstructured":"Shrestha NK, Mason P, Gordon SM, Neuner E, Nutter B, O'Rourke C, Rehm SJ. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study. J Antimicrob Chemother. 2014, 69:1407-15. 10.1093\/jac\/dkt512","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy287","article-title":"Effect of statin coadministration on the risk of daptomycin-associated myopathy","volume":"67","author":"Dare RK","year":"2018","unstructured":"Dare RK, Tewell C, Harris B, et al.. Effect of statin coadministration on the risk of daptomycin-associated myopathy. Clin Infect Dis. 2018, 67:1356-63. 10.1093\/cid\/ciy287","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2006.11.006","article-title":"Eosinophilic pneumonia induced by daptomycin","volume":"54","author":"Hayes D Jr","year":"2007","unstructured":"Hayes D Jr, Anstead MI, Kuhn RJ. Eosinophilic pneumonia induced by daptomycin. J Infect. 2007, 54:e211-3. 10.1016\/j.jinf.2006.11.006","journal-title":"J Infect"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmedc.2008.07.010","article-title":"Acute respiratory failure due to daptomycin induced eosinophilic pneumonia","volume":"1","author":"Kakish E","year":"2008","unstructured":"Kakish E, Wiesner AM, Winstead PS, et al.. Acute respiratory failure due to daptomycin induced eosinophilic pneumonia. Respir Med. 2008, 1:235-7. 10.1016\/j.rmedc.2008.07.010","journal-title":"Respir Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10040446","article-title":"Risk factors of daptomycin-induced eosinophilic pneumonia in a population with osteoarticular infection","volume":"10","author":"Soldevila-Boixader L","year":"2021","unstructured":"Soldevila-Boixader L, Villanueva B, Ulldemolins M, et al.. Risk factors of daptomycin-induced eosinophilic pneumonia in a population with osteoarticular infection. Antibiotics (Basel). 2021, 10:10.3390\/antibiotics10040446","journal-title":"Antibiotics (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02349-z","article-title":"Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series","volume":"52","author":"Gidari A","year":"2024","unstructured":"Gidari A, Pallotto C, Francisci D. Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series. Infection. 2024, 52:2145-68. 10.1007\/s15010-024-02349-z","journal-title":"Infection"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1355247","article-title":"Acute and chronic eosinophilic pneumonia: an overview","volume":"11","author":"Carbone RG","year":"2024","unstructured":"Carbone RG, Puppo F, Mattar E, Roden AC, Hirani N. Acute and chronic eosinophilic pneumonia: an overview. Front Med (Lausanne). 2024, 11:1355247. 10.3389\/fmed.2024.1355247","journal-title":"Front Med (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348907-a-case-of-daptomycin-induced-eosinophilic-pneumonia-and-its-management-insights","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T17:37:05Z","timestamp":1745948225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348907-a-case-of-daptomycin-induced-eosinophilic-pneumonia-and-its-management-insights"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.83195","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}